Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD4 cell counts at the third month of HAART may predict clinical failure.
d'Arminio Monforte A, Testori V, Adorni F, Castelnuovo B, Bini T, Testa L, Moscatelli G, Chiesa E, Rusconi S, Abeli C, Sollima S, Musicco M, Meroni L, Galli M, Moroni M. d'Arminio Monforte A, et al. Among authors: sollima s. AIDS. 1999 Sep 10;13(13):1669-76. doi: 10.1097/00002030-199909100-00010. AIDS. 1999. PMID: 10509568
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.
d'Arminio Monforte A, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli GC, Abeli C, Rusconi S, Sollima S, Balotta C, Musicco M, Galli M, Moroni M. d'Arminio Monforte A, et al. Among authors: sollima s. AIDS. 1998 Sep 10;12(13):1631-7. doi: 10.1097/00002030-199813000-00010. AIDS. 1998. PMID: 9764782 Clinical Trial.
Outcome of a second-line protease inhibitor-containing regimen in patients failing or intolerant of a first highly active antiretroviral therapy.
Bini T, Testa L, Chiesa E, Adorni F, Abeli C, Castelnuovo B, Melzi S, Sollima S, Bongiovanni M, d'Arminio Monforte A. Bini T, et al. Among authors: sollima s. J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):115-22. doi: 10.1097/00126334-200006010-00005. J Acquir Immune Defic Syndr. 2000. PMID: 10935686 Clinical Trial.
Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen: a retrospective cohort study.
Bongiovanni M, Bini T, Tordato F, Cicconi P, Melzi S, Repetto D, Sollima S, Rusconi S, d'Arminio Monforte A. Bongiovanni M, et al. Among authors: sollima s. J Antimicrob Chemother. 2003 Jan;51(1):171-4. doi: 10.1093/jac/dkg045. J Antimicrob Chemother. 2003. PMID: 12493805 Free article.
Indinavir-related alopecia.
d'Arminio Monforte A, Testa L, Gianotto M, Gori A, Franzetti F, Sollima S, Bini T, Moroni M. d'Arminio Monforte A, et al. Among authors: sollima s. AIDS. 1998 Feb 12;12(3):328. AIDS. 1998. PMID: 9517999 No abstract available.
Protease inhibitors and erectile dysfunction.
Sollima S, Osio M, Muscia F, Gambaro P, Alciati A, Zucconi M, Maga T, Adorni F, Bini T, d'Arminio Monforte A. Sollima S, et al. AIDS. 2001 Nov 23;15(17):2331-3. doi: 10.1097/00002030-200111230-00020. AIDS. 2001. PMID: 11698712 No abstract available.
AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
Antinori S, Ridolfo A, Fasan M, Magni C, Galimberti L, Milazzo L, Sollima S, Adorni F, Giuliani G, Galli M, Corbellino M, Parravicini C. Antinori S, et al. Among authors: sollima s. HIV Med. 2009 Jan;10(1):6-11. doi: 10.1111/j.1468-1293.2008.00645.x. HIV Med. 2009. PMID: 19125961 Free article.
Red herrings.
Sollima S, Corbellino M, Castelnuovo B, Tosoni A, Antinori S. Sollima S, et al. Lancet. 2003 Sep 13;362(9387):876. doi: 10.1016/S0140-6736(03)14343-7. Lancet. 2003. PMID: 13678975 No abstract available.
52 results